Our Taiwan patent on intravesical xenogeneic urothelail cell immunotherapy for bladder cancer has been issued! 由 eXCELL 發佈 | 2024-07-31 Our Taiwan patent on 2024 New Breakthrogh~ US patent on xenogeneic urothelial cell therapy on bladder cancer has been issued 由 eXCELL 發佈 | 2024-02-08 The United States Pa 2023 eXCELL Biotech Received a Japan Patent for the method to manufacture xenogeneic urothelial cells and the theraputic use of intravesical administration of xenogeneic urothelial cells to treat bladder cancer and cystitis. 由 eXCELL 發佈 | 2023-07-08 The Japan Patent Off
